BioSpace News Archive

GenesisCare—one of the leading oncology providers in the United States, Australia, Spain, and the United Kingdom—today announced it will administer the first commercially available dose of Lantheus’ new prostate cancer imaging agent, PYLARIFY (piflufolastat F 18) Injection

The 4th global SDARTs conference features a highly respected faculty in the latest scientific data and techniques for using adipose (fat) tissue as an abundant source of regenerative cells.

Health Canada is warning Canadians of the serious danger posed by two magnet sets, Xing da Toy Circular Magnets and Xing da Toy Oval Magnets sold in Canada.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

The Lung Cancer Research Foundation (LCRF) is excited to announce a partnership with leading lung cancer patient advocacy group, the EGFR Resisters.

The BIOTECanada Board of Directors is pleased to announce the election of Gordon C. McCauley, President and CEO, AdMare BioInnovations, as Chairman of BIOTECanada at ’s Annual General Meeting.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced publication of open-label extension (OLE) data from patients experiencing hallucinations and delusions associated with Parkinson’s disease psychosis (PDP) who had previously completed one of three, six-week, double-blind, placebo-controlled studies.

Q2 Solutions and MindX Sciences Inc., a company that works to improve lives through empowering precision medicine approaches to mental health, today announced a partnership, where Q2 Solutions will be conducting genomics laboratory testing services for MindX Sciences blood tests.

Launching with a commitment to listen to women to understand her health needs and help identify solutions that are urgently needed

US Oncology Research, The US Oncology Network (The Network), and OntadaTM announce they contributed to more than 75 studies covering topics including gynecologic cancer, lung cancer and immunotherapy which will be presented at the upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4 - 8.